No Data
No Data
IBio Reports Q3 Results
iBio Inc | 10-Q: Quarterly report
IBio Q3 EPS $(0.71) Up From $(9.53) YoY
iBio (AMEX:IBIO) reported quarterly losses of $(0.71) per share. This is a 92.55 percent increase over losses of $(9.53) per share from the same period last year.
IBio 3Q Rev $0 >IBIO
IBio 3Q Rev $0 >IBIO
Press Release: IBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update -- Strengthened cash position with investment by healthcare specialist investors -- Expanding into c
The coronavirus hasn't disappeared yet! A new “FlIRt variant family” is spreading in the US...
① According to CDC data, the main variant of transmission in the US today is the “FlIRT” family, led by KP.2; ② KP.2 accounts for 25%; ③ medical experts warn that fLiRT has a more obvious transmission advantage and may trigger a new wave of COVID-19.